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glycoprotein N-linked and O-
linked glycans is greatly
enhanced by permethylation
following release from the
protein backbone. HPLC of
permethylated glycans resolves
isomeric glycans that are difficult
to discern by direct infusion
methodologies. An approach is
described that utilizes standard
peptide separation columns and
accessible instrumentation. The
methodology is easily adoptable
by laboratories already familiar
with LC-based peptide
separations to achieve isomeric
resolution of glycans released
from biological materials.
Highlights
• LC separation of N- and O-linked glycans as their permethylated derivatives.
• Glycan isomers resolved on reversed phase columns commonly used for peptides.
• Analytes identified by exact mass and retention time relative to glycan standards.
• Structural topologies validated by on-the-fly MSn using accessible instrumentation.
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Separation and Identification of Permethylated
Glycan Isomers by Reversed Phase NanoLC-
NSI-MSn
Simone Kurz1,‡ , M. Osman Sheikh1,‡ , Shan Lu2, Lance Wells1,3,* , and
Michael Tiemeyer1,3,*
HPLC has been employed for decades to enhance
detection sensitivity and quantification of complex analy-
tes within biological mixtures. Among these analytes,
glycans released from glycoproteins and glycolipids have
been characterized as underivatized or fluorescently tag-
ged derivatives by HPLC coupled to various detection
methods. These approaches have proven extremely useful
for profiling the structural diversity of glycoprotein and
glycolipid glycosylation but require the availability of
glycan standards and secondary orthogonal degradation
strategies to validate structural assignments. A robust
method for HPLC separation of glycans as their per-
methylated derivatives, coupled with in-line multidimen-
sional ion fragmentation (MSn) to assign structural
features independent of standards, would significantly
enhance the depth of knowledge obtainable from biolog-
ical samples. Here, we report an optimized workflow for
LC-MS analysis of permethylated glycans that includes
sample preparation, mobile phase optimization, and MSn
method development to resolve structural isomers on-the-
fly. We report baseline separation and MSn of isomeric N-
and O-glycan structures, aided by supplementing mobile
phases with Li+, which simplifies adduct heterogeneity
and facilitates cross-ring fragmentation to obtain valuable
monosaccharide linkage information. Our workflow has
been adapted from standard proteomics-based work-
flows and, therefore, provides opportunities for labora-
tories with expertise in proteomics to acquire glycomic
data with minimal deviation from existing buffer systems,
chromatography media, and instrument configurations.
Furthermore, our workflow does not require a mass
spectrometer with high-resolution/accurate mass capa-
bilities. The rapidly evolving appreciation of the biological
significance of glycans for human health and disease re-
quires the implementation of high-throughput methods to
identify and quantify glycans harvested from sample sets
of sufficient size to achieve appropriately powered
statistical significance. The LC-MSn approach we report
generates glycan isomeric separations and robust struc-
tural characterization and is amenable to autosampling
with associated throughput enhancements.
Every living cell is covered in a dense and complex array of
glycoconjugates that modulate various biological processes
such as molecular recognition, cell–cell, and cell–matrix in-
teractions. The structural diversity of glycans arises from dif-
ferences in monosaccharide compositions, anomeric
confirmation, glycosidic linkages, branching, and their attach-
ment to protein or lipid (1). A hallmark of protein glycosylation is
the phenomenon of microheterogeneity or the property that
any single glycosylation site may be unmodified or modified by
more than one glycan structure when comparing molecules of
the same protein, even if produced in the same cell type. This
diversity presents unique challenges for characterizing glyco-
protein glycosylation and creates vital needs for technologies
that robustly capture glycan structural details (2). The
biochemical and analytical tools currently deployed for glyco-
mic analysis are almost as diverse as the biological roles of
glycans and are highly influenced by the research purpose.
Given the complexity of glycan structures, with special
reference to the broad range of isomeric possibilities, glycan
separation by LC has emerged as a state-of-the-art approach
in glycomics. Almost all previous LC work has been done on
underivatized or fluorescently tagged glycans, allowing high
sensitivity of detection and high resolution separations based
on size, charge, and hydrophobicity (3). These approaches
require previously characterized glycan standards as refer-
ence materials or sequential enzymatic (e.g., exoglycosidase
sequencing) and/or chemical treatments (e.g., hydrofluoric
acid) for complete glycan characterization. While offline or
online MS-based methods can be combined with tagged-
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glycan separations, the sensitivity and information content of
the resulting data is significantly influenced by the ionization
characteristics and chemical nature of the tag. In that respect,
permethylation has emerged as a routine derivatization pro-
cedure that improves sensitivity by enhancing MS ionization.
Glycan permethylation converts the oxygen of all hydroxyl
groups, including the sialic acid carboxylates, into an O-
methyl groups (O-CH3). Because glycans generally have a
large number of free hydroxyls, the O-methyl groups of per-
methylated glycans dominate the chemical behavior of the
molecule, enhancing and equalizing ionization across diverse
glycan structures (4). Permethylation thereby allows for the
analysis and quantification of acidic and neutral structures in
the mass spectrometer's positive ion detection mode.
In sequential fragmentation MS/MS and MSn analysis,
“scars” of a free hydroxyl group instead of O-methyl are
detected at the original position of glycosidic linkages, thereby
providing valuable linkage information through cross-ring
cleavages. Permethylation and heavy metal cations facilitate
these cross-ring fragments enabling in-depth structural char-
acterization of glycans by direct infusion into the mass
spectrometer without LC separation (5–8). However, structural
elucidation of isomeric permethylated glycans poses analytic
challenges in direct infusion MS because they are detected at
the same m/z. This complication can be conquered by
combining LC separation of permethylated glycans with
intelligent MSn in realtime. Various LC-MS methods for
analyzing permethylated glycans have been published
recently (9, 10). Here, we report our solution, which is
designed to be rapidly adaptable by laboratories familiar with
standard proteomic workflows. Using an Ultimate 3000 RSLC
HPLC system coupled to a Velos Pro Dual Pressure Linear Ion
Trap, we describe parameters of sample preparation, mobile
phase and gradient optimization, as well as postacquisition
data analysis of permethylated chemically synthesized stan-
dards and glycans released from either standard proteins or
biological sample mixtures. We have achieved baseline sep-
aration and MSn of isomeric N- and O-glycan structures to aid
in confident identification and quantification by pushing the
ionization into a single adduct form, namely lithium. Our
workflow simplifies postacquisition data analyses and en-
hances throughput of glycomic data collection without dras-
tically changing chromatography media used for proteomics




PNGase F (N-glycanase) was obtained from the Complex Carbo-
hydrate Research Center, University of Georgia, (Dr Kelley Moremen).
PNGase A was acquired from NEB. N-Glycan standards were ob-
tained from the Consortium for Functional Glycomics (CFG) and from
The Scripps Research Institute (Dr James Paulson). O-Glycan
standards were obtained as part of an NIH Common Fund grant
(R21AI123161) from the University of Georgia (Dr Christopher M.
West). Sodium hydroxide (NaOH) (50%) was purchased from Fisher
Scientific. Sep-Pak C18 disposable extraction columns were obtained
from Waters Corporation. AG-50W-X8 cation exchange resin (H+ form)
was purchased from Bio-Rad, and trifluoroacetic acid from Pierce.
Malto-series oligosaccharides were obtained from Wako Chemicals.
Trypsin, Chymotrypsin, bovine pancreatic ribonuclease B (RNaseB),
Fetuin, Dextran (Leuconostoc spp., Cat# 31388), and all other
chemical reagents were purchased from Sigma-Aldrich. Fly powder, a
dried preparation of Drosophila embryo glycoproteins, was prepared
as previously described and used as a source of pauci-mannose
glycans (11). Mouse brain extracts were prepared as previously
described for analysis of brain O-glycans (12). HIV gp120 was
recombinantly expressed in glyco-engineered Pichia pastoris strains
obtained from GlycoFi to generate proteins with restricted glycan di-
versity (13, 14).
Preparation of protein-rich powder and subsequent O-glycan
release
Primary mouse tracheal epithelial cells (mTECs), mouse brain (Pel-
Freez Biologicals), or HEK293 cells (kind gift from Dr Henrik Clausen,
University of Copenhagen, Denmark) were homogenized in ice-cold
50% (v/v) aqueous methanol and delipidated with chloroform/meth-
anol/water (4:8:3, v/v/v) as described previously (11, 15). Insoluble
proteins were precipitated by centrifugation, and protein pellets were
washed twice with ice-cold acetone before drying under a gentle Ni-
trogen stream to produce fine protein powder. Two to 3 mg of protein
powder was then subjected to reductive β-elimination, and the
released O-glycan alditols were purified as described previously (16).
Briefly, protein powder was resuspended in 100 mM NaOH containing
1 M sodium borohydride and incubated for 18 h at 45 ◦C in a glass
tube sealed with a Teflon-lined screw top. After incubation, the re-
action mixture was neutralized with 10% acetic acid (AcOH) on ice
and desalted using a AG-50W-X8 (H+ form) column (1 ml bed volume)
before borate removal and Sep-pack C18 cartridge clean-up.
Release and reduction of N-glycans
Preparation of glycopeptides and release of N-glycans was per-
formed as described previously (11). Briefly, 20 to 75 μg of glyco-
proteins (RNAse B, Fetuin, gp120) were dried and resuspended in
trypsin buffer (0.1 M Tris-HCl, pH 8.2, containing 1 mM CaCl2) by
sonication and boiled for 5 min before addition of trypsin and
chymotrypsin solutions. After incubation for 18 h at 37 ◦C, the (glyco)
peptide mixture was boiled for 5 min and adjusted to 5% AcOH before
a Sep-Pak C18 cartridge column clean up. Glycopeptides were eluted
stepwise in 20% isopropyl alcohol in 5% AcOH and 40% isopropyl
alcohol in 5% AcOH. Both, the 20 and 40% isopropyl alcohol fractions
were pooled and evaporated to dryness. Dried glycopeptides were
resuspended in 25 mM sodium phosphate buffer, pH 7.5, for digestion
with PNGaseF (fetuin, ribonuclease B) or in 50 mM ammonium acetate
buffer, pH 4.5, for digestion with PNGaseA (fly powder) before incu-
bation for 18 h at 37 ◦C. PNGase-released oligosaccharides were
separated from residual (glyco)peptides by another round of Sep-Pak
C18 cartridge clean-up.
For the reduction of PNGase-released N-glycans and standards,
dried glycans were resuspended in 100 μl of 50 mM NaOH, vortexed,
and ultrasonic water bath sonicated before the addition of 100 μl 2%
(w/v) sodium borohydride in 50 mM NaOH. After incubation for at least
4 h at RT, 200 μl of 10% (v/v) AcOH were added to neutralize the
reaction. Samples were dried down under a gentle nitrogen stream
before borate removal by adding 400 μl of 10% (v/v) AcOH in methanol
and repeated evaporation (up to three times).
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Permethylation
All released N- and O-linked glycans as well as standards were
permethylated before MS analysis according to the method by Anu-
mula and Taylor (17). Dextran, malto-series oligosaccharide standards
and CFG N-glycan standards were permethylated with 13C methyl-
iodide (13C-MeI).
nanoLC-MS/MS of permethylated glycans
Dried permethylated glycans and standards were dissolved in
100% methanol, and an aliquot (usually 5–10% of the total sample)
was combined with an internal standard mix (13C-permethylated de-
gree of polymerization [DP]4) and mobile phase A. For each nanoLC-
MS/MS analysis, 3 to 6 μl of the prepared sample mix was injected for
LC separation at 60 ◦C and a constant flow rate of 300 nl/min using an
Ultimate 3000 RSLC (Thermo Fisher Scientific/Dionex) equipped with
a PepMap Acclaim analytical C18 column (75 μm × 15 cm, 2 μm pore
size) coupled to a Thermo Fisher Scientific Velos Pro Dual-Pressure
Linear Ion Trap mass spectrometer (ITMS), ending with sample ioni-
zation via a stainless steel emitter. The three solvent systems used
were either 0.1% formic acid in water for mobile phase A and 0.1%
formic acid in 80% acetonitrile (ACN) for mobile phase B (“Proteomics
buffers”); 0.1% AcOH containing 0.1 mM lithium acetate (LiOAc) for
mobile phase A and 0.1% AcOH in 80% ACN containing 0.1 mM
LiOAc for mobile phase B (“Low lithium buffers”); or 0.02% AcOH
containing 1 mM LiOAc for mobile phase A and 0.02% AcOH in 80%
ACN containing 1 mM LiOAc for mobile phase B (“High lithium
buffers”).
For O-glycans, after equilibrating the column in 99% mobile phase
A for 5 min, separation was achieved using a linear gradient from 30%
to 70% mobile phase B over 150 min. For N-glycans, after equili-
brating the column in 99% mobile phase A for 5 min, separation was
achieved using a linear gradient from 45% to 70% mobile phase B
over 150 min. The analytical column was regenerated after each run by
ramping to 99% mobile phase B for 10 min and then returning to 99%
mobile phase A to re-equilibrate.
The Velos Pro Dual Pressure Linear ITMS was operated in positive
ion mode with a spray voltage of 1.8 to 2.2 kV and capillary temper-
ature set at 210 ◦C. The MS method consisted of first collecting a Full
ITMS (MS1) survey scan in profile mode and m/z mass range from 500
to 2000 with automatic gain control Target set to 30,000.00, followed
by data-dependent MS2 fragmentation of the top 3 to 5 most intense
peaks using collision-induced dissociation at 40 to 42% collision
energy and an isolation window of 2 m/z. Dynamic exclusion param-
eters were set to exclude ions for fragmentation for 15 s if they were
detected and fragmented five times in 15 s. For targeted MSn ap-
proaches, intelligent fragmentation methods were generated using
neutral loss function and product dependent MS3-5 acquisition to
determine sialic acid linkage of terminally sialylated N-glycan struc-
tures. To normalize elution times on the RP-column in terms of g.u.,
13C-permethylated dextran (4–10 g.u.) was analyzed before and after a
sequence of samples. After the completion of a sample set, in prep-
aration for limited HPLC use for an extended period of time, the
postcolumn-fused silica lines were manually flushed with 50%
methanol in water to avoid clogging of the stainless steel emitter with
lithium salts. All data were processed manually using the Xcalibur
software package 2.0. GRITS Toolbox; a freely available tool for
semiautomated annotation of glycomic MS data was also employed to
generate candidates for structural assignment (18). The GRITS
Toolbox parameters used for annotations were set as follows: all
glycosidic and cross-ring cleavage types enabled (B, Y, C, Z, A, X);
maximum number of cleavages and cross-ring cleavages, 2; mass
type, average; mass accuracy for full MS, 1 Da; mass accuracy for
MSn, 250 ppm; precursor intensity cut-off, 5%; database, “N-glycans
(topology)” with prefilter human monosaccharides enabled; reducing
end, reduced; PerDeriv type, perMe; derivative mass and adduct were
set according to experimental conditions, isotopically heavy methyl
(13C-MeI) or Na/Li as appropriate. Raw mass spectrometry data files
have been deposited at GlycoPOST (https://glycopost.glycosmos.
org/) under the Accession ID number GPST000123.
RESULTS
Sample preparation
Our workflow can be applied to any biological starting
material. In the first preparation steps, glycosphingolipids are
extracted from the biological sample before acetone precipi-
tation to obtain protein rich powder (Fig. 1). Starting with 1 to
2 mg of protein powder each, we can prepare N- and O-gly-
cans. For N-glycans, the glycoproteins are proteolytically
cleaved into glycopeptides (usually by trypsin and/or chymo-
trypsin) and purified using a C18 solid-phase extraction col-
umn. N-glycans are then enzymatically released with PNGase
F. For liquid chromatography-nanospray ionization-mass
spectrometry (LC-NSI-MS) analysis, released N-glycans can
FIG. 1. General workflow for preparation of N- and O-glycans.
Using virtually any biological source as starting material, protein-rich
powder can be generated via organic delipidation as described pre-
viously. N-linked glycans can be released enzymatically (PNGase F or
PNGase A) followed by mild reduction of the free reducing terminus.
O-linked glycans can be released chemically via reductive β-elimina-
tion. Released glycans of either class are subjected to permethylation
followed by direct analysis by LC-NSI-MS. Symbol and Text nomen-
clature for representation of glycan structures is displayed according
to the Symbol Nomenclature for Glycans (SNFG) (39). LC-NSI-MS,
liquid chromatography-nanospray ionization-mass spectrometry.
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also be reduced in mild sodium borate conditions before
borate removal and permethylation for improved chromato-
graphic separation (see supplemental Fig. S1). O-glycans are
chemically released by reductive β-elimination, followed by
desalting, borate removal, and C18 clean up. Following per-
methylation and phase partitioning, we subjected the organic
phase, which contains neutral and nonsulfated glycans, to
analysis by LC-NSI-MS using various buffer and gradient
conditions.
O-glycan separation and mobile phase optimization
To test the separation of permethylated O-glycans using our
platform, initial RP C18 nanoLC-separations were performed on
O-glycans released by reductive beta-elimination from primary
mTEC. These initial separations used conventional acidic pro-
teomic mobile phases at an elevated column oven temperature
(60 ◦C) to facilitate baseline separation (Fig. 2A). As has been
previously describedandalso inour analysis, lower columnoven
temperatures (40 ◦C and 50 ◦C) resulted in significant peak
broadening (10). By generating extracted ion chromatograms
(EICs) of expected glycan species, the major mTEC O-glycans
were resolved, and multiple EIC peaks were identified for some,
revealing the possibility of isomeric structures (Fig. 2B).
One disadvantage of using acidic mobile phases that are
standard for proteomic analyses is the formation of multiple
alkali metal glycan adducts which makes data analysis and,
importantly, quantification more difficult. As demonstrated for
a simple sialyl Tn O-glycan structure, multiple ions including
protonated [M + H]+, lithiated [M+Li]+, sodiated [M+Na]+, and
potassiated [M + K]+ adducts were detected in a Full MS scan
using conventional proteomics mobile phases (Fig. 2C). To
promote the ionization into only one molecular ion species and
to enhance cross-ring cleavages, LiOAc was supplemented in
the mobile phases at 0.1 mM resulting in an improvement but
not complete shift toward lithiated ion species. By increasing
the concentration to 1 mM LiOAc and reducing acid con-
centration, adduct ions were shifted to essentially lithiated-
only forms (Fig. 2C). Combining EICs with the data-
dependent MS/MS data acquisition in real-time, the struc-
tures of two isomeric sialyl Tn O-glycans were resolved with
the minor branched structure eluting earlier (35 min) than the
more abundant linear structure (42 min) (Fig. 2D).
FIG. 2. Addition of lithium acetate to LC-mobile phases enhances ionization. Reduced O-glycans from mouse tracheal epithelial cells
(mTECs) were separated on a PepMap Acclaim C18 column (75 μm × 15 cm, 2 μm pore size) using three different mobile phase pairs (Buffers A
and B) on a Dionex UltiMate 3000 coupled to Thermo Velos Pro ITMS. A, the total current chromatogram and extracted ion chromatograms (B)
demonstrate baseline separation of permethylated O-glycans using common proteomics buffers (Formic acid/Acetonitrile). C, observed alkali
metal adduct ions for the three mobile phase conditions tested demonstrated optimal ionization and adduct formation in 0.02% acetic acid
containing 1 mM lithium acetate. D, MS/MS fragmentation of two glycan isoforms are shown.
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N-glycan separation and gradient optimization
To assess the feasibility of separating permethylated N-
glycans, we used PNGaseF-released N-glycans from RNAseB
as our glycan source. Initial peak-splitting during the LC-
separation was observed, presumably because of muta-
rotation of the anomeric configuration at the free reducing end
before permethylation (α- versus β-anomer; supplemental
Fig. S1A). To ameliorate this complication, reduction of
PNGase-released N-glycans before permethylation is strongly
recommended for simplifying glycans to elute as one peak
rather than two α- and β-anomer peaks (supplemental Fig. 1B).
Peak splitting was not observed in our mTEC O-glycan anal-
ysis because the reducing termini of the released O-glycans
are reduced during the release by reductive β-elimination as
part of our standard workflow (Fig. 1).
Using an initial separation gradient of 30% to 70% mobile
phase B over 150 min, baseline separation was achieved for
reduced and permethylated paucimannosidic, high-mannose,
and complex type N-glycan structures released from fly pro-
tein powder, RNAseB, and Fetuin, respectively (Fig. 3A). As
this gradient might be insufficient for separation of larger
N-glycans such as tetra-antennary structures, a modified
gradient with a rapid increase in the first 5 min to 45% B
followed by a shallow gradient of 45% to 70%B over 150 min
was applied and was observed to not change the overall
elution pattern of the tested N-glycans (Fig. 3B). Using our
platform and elution conditions, attempts to shorten the
gradient to less than 180 min as described by others resulted
in suboptimal separation of glycans and increased numbers of
co-eluting species (3, 9, 10).
Chromatographic retention times can be converted to
glucose units
In many instances, the combination of LC retention time and
accurate mass of a detected analyte can lead to structural
assignment by reference to well-characterized standards.
However, assignment/annotation solely based on retention
time and mass is frequently impractical because of technical
challenges associated with variability in column performance,
clogged tubing, clogged emitters, etc. Therefore, a more
robust relationship between glycan structure and retention
time can be achieved by referencing glycan elution positions
to a hexose polymer ladder, yielding retention times in glucose
units or g.u (19, 20). Dextran polymers ranging in length (DP)
from 4 to 10 monosaccharide units where reduced and per-
methylated with 13C-MeI to produce a dextran reference lad-
der of g.u. standards (DP4-10). Aliquots of the reference
ladder were injected before and after sample acquisition
queues, and the resulting retention times were averaged from
EICs for each predicted mass within 10 ppm (Fig. 4A).
To test the robustness of our method for characterizing the
elution positions of glycans with greater complexity than the
dextran ladder, we analyzed four CFG standards (107, 108,
109 and 110) which represent bisected, complex branched
N-glycans and one CFG standard (121), a sialylated
biantennary N-glycan. Separation of all five reduced and
FIG. 3. LC-gradient optimization for reduced N-glycans. A, initial separation of paucimannose, high-mannose, and complex-type
N-glycans was achieved with a gradient from 30 to 70% B, but separation of larger N-glycans (e.g., tetra-antennary) might be insufficient.
B, Rapid increase in the gradient to 45% B in 5 min followed by a shallow gradient from 45 to 70% B seems to be more suitable for larger
N-glycans (e.g., tri/tetra-antennary). Attempts to shorten the gradient program to less than 180 min using steeper gradients resulted in sub-
optimal separation of glycans and co-eluting species.
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FIG. 4. Elution of permethylated gly-
cans expressed in terms of glucose
units. A, reduced and 13C-permethylated
Dextrans (isomaltooligosaccharide se-
ries, DP4 to 10) were separated using a
PepMap Acclaim C18 column in 1 mM
lithium acetate-containing mobile phases
(45–70% B over 150 min). Extracted ion
chromatogram for each predicted mass
is shown (within 10 ppm). Retention times
of DP standards, run both before and
after sample acquisition queue, were
averaged and plotted using a linear
regression fitting. Error bars represent
standard deviation (See inset).
B, reduced and 13C-permethylated CFG
N-Glycan standards (107–110, 121) were
analyzed as described in (A). C, summary
table of analyzed CFG standards with
retention times converted to reversed
phase glucose units (RP g.u.) using linear
regression fitting shown in A, inset. CFG,
Consortium for Functional Glycomics;
DP, degree of polymeriation.
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13C-permethylated CFG standards was achieved resulting in
standard 107 (bisected, biantennary N-glycan) eluting before
standard 108 (bisected, triantennary N-glycan with two
GlcNAc residues attached to the core α1,3 mannose). Inter-
estingly, a gap of 6 min in retention time was detected be-
tween the elution of the isomeric structure of standard 108,
which is standard 109 (bisected, triantennary N-glycan with
two GlcNAc residues attached to the core α1,6 mannose)
demonstrating the power of our modified gradient to achieve
separations based on size and hydrophobicity (Fig. 4B). CFG
standard 110 (bisected, tetra-antennary N-glycan) eluted
approximately 2.6 min after standard 109 and before the final
sialylated, biantennary N-glycan standard 121. Using the
linear regression fitting from the dextran ladder runs before
and after the sample queue, the observed retention times were
converted to reverse phase glucose units (RP g.u.) to express
the elution positions of the analyzed CFG standards (Fig. 4C).
Dextran ladder was analyzed before a large sample acquisition
queue and subsequently after 25 days of continuous opera-
tion (supplemental Fig. S2). Retention times of isomaltose
polymers after nearly 1 month of continuous use were
consistent within 2 to 3%. Furthermore, retention times were
consistent regardless of amount injected, in a dynamic range
of 15.6 to 1000 fmol of injected standard (supplemental
Fig. S3).
Similar to the N-glycan standards, we tested the ability of
our method to separate chemically synthesized, reduced, and
13C-permethylated O-glycan isomeric standards derived from
the human pathogen Trypanosoma cruzi, the causative agent
for Chagas disease in South America (21, 22). The four tet-
rasaccharide O-glycan isomers analyzed only differ by either
the cyclic form of a single monosaccharide (pyranose or
furanose) or a single linkage. Owing to the very small differ-
ences in isomeric confirmation between these four mono-
saccharides, a modified gradient was applied (35–40% B over
170 min) (Fig. 5). The four standards were analyzed separately
(Fig. 5, A–D) or as a mixture (Fig. 5E) and demonstrated nearly
baseline separation using the modified gradient program. Of
the four isomeric O-glycan structures, the pyranose structures
eluted over 20 min earlier than furanose-containing isoforms.
As described previously, the observed retention times were
converted to RP g.u. using the linear regression fitting from
dextran ladder runs before and after the sample queue using
the same gradient program (Fig. 5F).
Characterization of N-glycans released from recombinant
HIV gp120 expressed in glyco-engineered P. pastoris
The data described above demonstrates the ability of our
method to resolve N- and O-glycan structures derived from
abundant glycoproteins or prepared as synthetic standards.
To assess the applicability of our method for detecting bio-
logically relevant glycosylation patterns, we analyzed N-gly-
cans released from recombinantly expressed HIV gp120
envelope glycoproteins harvested from six different glyco-
engineered strains of P. pastoris (13, 14). Each of these
strains lack glycosyltransferase activities that result in the
generation of restricted cellular N-glycan profiles predicted to
be to predominated by specific high-mannose or complex
type glycans. After release, reduction, and permethylation, N-
glycans from each gp120 preparation were first separated and
analyzed individually, demonstrating that the detected N-gly-
cans are consistent with the targeted glycosyltransferases in
each glyco-engineered strain (Fig. 6, A–F). For example, N-
glycans of the composition Hex3HexNAc2-ol were only
detected in the strain engineered to generate Man3GlcNAc2
structures on gp120 glycoprotein (Fig. 6A) and Hex5HexNAc2-
ol in the Man5GlcNAc2 engineered strain (Fig. 6B). A similar
pattern was observed in engineered strains producing only
Man8GlcNAc2 and Man9GlcNAc2 as well as Hex8HexNAc2-
Hex10HexNAc2 structures (Fig. 6, C and D). Pichia strains
engineered to synthesize N-glycan structures with terminal
galactose residues or terminal sialic acid modifications also
exhibited Man5GlcNAc2 structures in addition to the expected
complex type structures (Fig. 6, E and F). To assess the ca-
pacity of our LC-MS system to resolve the range of glycans
released from these expression platforms, we mixed equal
amounts of each sample and analyzed as described above.
We were able to accurately detect and resolve all of the
various N-glycan structures derived from the recombinant
gp120 glycoforms that were detected when each were
analyzed individually (Fig. 6G). Furthermore, we applied an
automated MSn workflow which targeted the neutral loss of
permethylated sialic acid (Δm/z = 375) to trigger product
dependent MS3-5 acquisitions. Because lithium was included
in the LC separation mobile phases, this workflow revealed
that the terminal sialic acids of the N-glycan structures
released from these gp120 preparations are α2,6-linked
(Fig. 6, H and I).
Analysis of O-glycan isomers from biological samples
O-linked glycans linked to Ser/Thr residues can be divided
into various subtypes depending on the initiating mono-
saccharide linked directly to the polypeptide backbone. The
most abundant class is the mucin-type O-GalNAc-initiated
structures. Other types of O-glycans include O-Mannose,
O-Fucose, O-Glucose, O-GlcNAc, O-Xylose, all of which have
diverse biological functions (23, 24). Previous studies have
documented the detection of both O-GalNAc and
O-Mannose-initiated disaccharides and Galβ3GalNAc and
GlcNAcβ2Man, respectively, in mouse brain (12, 25). In direct
infusion MS, these glycans are detected at the same m/z
because they have the same Hex1HexNAc1 composition.
While MS/MS fragmentation of the permethylated di-
saccharides can detect the presence of these two glycans, the
fragmentation patterns of the isolated ions can be compli-
cated as they are a mix of the two species and quantification
of each individual disaccharide is problematic. To identify the
presence or absence of Hex1HexNAc1 isomers in mouse
nanoLC-NSI-MSn of permethylated glycans
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FIG. 5. LC-NSI-MS of Permethylated Isomers. A, extracted ion chromatograms showing individual (A–D) or a mixture (E) of four O-glycan
tetrasaccharide isomers that only differ by the cyclic form of a single sugar [pyranose (p) or furanose (f)] or a single linkage (differences indicated
in green). Separation was performed using a PepMap Acclaim C18 column in 1 mM lithium acetate-containing mobile phases with a modified
gradient (35–40% B over 170 min) and detected using a Thermo Velos Pro ITMS. F, summary table of isomers used with retention times
converted to reversed phase glucose units (RP g.u.; referenced to 13C-permethylated isomaltooligosaccharide standards separated using the
same gradient). LC-NSI-MS, liquid chromatography-nanospray ionization-mass spectrometry.
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brain, we analyzed the released and permethylated glycans by
our LC-MS workflow (Fig. 7A). An EIC of the expected singly
charged, lithiated structures (m/z 518.3) revealed two peaks of
differing relative abundance at 17.8 and 19.2 min. MS2 frag-
mentation of m/z 518 at the respective times is consistent with
the HexNAc-initiated disaccharide (O-GalNAc) eluting earlier
than the Hexose-initiated structure (O-mannose), as deter-
mined by unique fragments at the reducing terminus (Fig. 7A,
insets).
We also analyzed O-glycans harvested from cells that were
glyco-engineered to be deficient in the O-Mannosylation
pathway implicated in congenital muscular dystrophies
FIG. 6. LC-NSI-MSn analysis of N-glycans released from recombinant gp120 expressed in Pichia pastoris strains defective in
N-glycosylation machinery. A, extracted ion chromatograms of all predicted PNGaseF-released, reduced, and permethylated N-glycans from
various gp120 expressing cell lines, either individually (A–F) or as a mixture (G). H, automated, intelligent MSn defines sialic acid linkage position
in realtime from Structure #10. I, summary table of gp120 N-glycans with retention times converted to reversed phase glucose units (RP g.u.;
referenced to 13C-permethylated isomaltooligosaccharide standards separated using the same gradient). LC-NSI, liquid chromatography-
nanospray ionization; MSn, multidimensional ion fragmentation.
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(26–28). The glycosyltransferase POMGNT1 (Protein O-Linked
Mannose N-Acetyl-glucosaminyltransferase 1) transfers β2-
linked GlcNAc to an underlying α-mannose linked to Ser or
Thr to generate Core M1-type glycans which can be further
extended by B4GALT1 with β4-linked galactose (29). O-gly-
cans were released from glycoproteins harvested from
FIG. 7. Analysis of reduced and permethylated O-glycans released from mouse brain proteins and human cell lines defective in the
O-mannosylation pathway. A, extracted ion chromatogram of Hex1HexNAc1 structures released from mouse brain proteins indicates two
structural isomers. MS2 fragmentation of m/z 518.3 at the indicated retention times are shown as insets. B, LC-MS analysis of O-glycans
released from HEK293 WT and ΔPOMGNT1 mutant cell lines. Respective EICs and annotated MS2 spectra are shown. EICs, extracted ion
chromatograms.
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HEK293 wildtype cells or HEK293 cells harboring a Crispr-
Cas9-mediated global disruption of the POMGNT1 locus (30).
As a control, a non-O-Mannose structure (Xylα3Xylα3Glc-ol),
which modifies a consensus found in the EGF repeats of a
relatively small number of proteins (31–33), was detected (m/z
593.3 [M+Li]+) in both samples (Fig. 7B). An EIC of m/z 722.1
([M+Li]+) which corresponds to the composition Hex2HexNAc1
(O-mannose Core M1 structure, Galβ4GlcNAcβ2Man-ol)
demonstrates the presence of the glycan in HEK293 WT but
not in the POMGNT1-deficient cell line.
DISCUSSION
The field of glycomics has historically been eager to engage
new analytic platforms based on their promise to deliver
greater sensitivity and enhanced detection of structural fea-
tures (34–37). Despite tremendous advances in various ana-
lytic technologies, it remains true that no single technique,
besides NMR, is capable of routinely and completely defining
glycan structures. Thus, the field will continue to benefit from
the development of an expanding array of analytic ap-
proaches. We have combined two powerful technologies,
glycan permethylation and LC, in a manner that should be
adoptable by analytic laboratories familiar with standard LC-
MS/MS proteomic techniques. To facilitate adoption of our
nanoLC-NSI-MSn approach, we have optimized run condi-
tions and buffer compositions for analysis of N-linked or
O-linked glycans. Using these conditions, we achieved
baseline separations of challenging isomeric glycans and also
demonstrated the power of on-the-fly MSn to distinguish
structural features such as the linkage position of sialic acids.
Other investigators have previously described LC-based
separations of glycans and, more particularly, of per-
methylated glycans (3, 9, 10). These approaches are all valu-
able contributions to the arsenal of glycomic technology. In
many cases, these techniques make use of glycan standards
to define the retention times of known structures, generating a
database of RT values that, when combined with accurate
mass detection, can provide confident identification of com-
ponents in complex mixtures. Glycans with novel RT values
can be at least partially characterized using these methods by
applying off-line exoglycosidase digestions (sequencing) and
re-analysis (37). Our approach is also amenable to off-line
exoglycosidase digestion with re-analysis, takes advantage
of RT and accurate mass, and will, over-time build a library of
RP g.u. values to help define structural features of novel gly-
cans. The resolving power of our method is most clearly
demonstrated by its ability to generate near-baseline separa-
tion of four tetrasaccharides that share the same mono-
saccharide composition and topology but differ only in a
single linkage position (see Fig. 5). To this resolving power, we
add the capability of capturing MSn data on-the-fly to help
assign structures with novel RT values in a single analytic run
(see Figs. 6 and 7). The inclusion of lithium in the mobile phase
enhances this capability by facilitating the generation of cross-
ring fragments indicative of specific structural features (5).
We optimized the lithium concentration in the mobile phase
so that we detect glycans as a single adduct species. This
simplification allows quantification to be done from peak areas
detected in MS1 for a single adduct, enhancing sensitivity and
resolution of glycan species across the chromatogram. As
mentioned above, our method incorporates the inclusion of
RT standards (DP4-10) which allows the calculation of relative
retention times in Glc units (RP g.u.), facilitating cross-platform
and run-to-run identification of glycans of interest. We have
previously demonstrated that permethylated glycans yield
nearly the same signal intensity regardless of their mass or
complexity, unless modified with sulfate or phosphate (4).
Thus, known amounts of DP standards can not only serve as
RP g.u. references but may facilitate quantification of molar
amounts of analyte. However, additional work is required to
determine whether this approach can be validated as semi-
quantitative or can provide absolute quantitation across
various classes of glycans. A current limitation of our
approach is the need for well-defined glycan standards to fully
characterize complex mixtures of unknown structures. Ideally,
a standard would be available for every glycan in the analyte
and, over time, extensive tables of RP g.u. values would be
generated to facilitate rapid identification of components of
interest. Confidence in the usefulness of RP g.u. tables
populated by our approach will be heightened by the MSn data
that are generated to support structural features of standards
or mixtures of standards.
Previously published glycomic studies from our laboratories
and many others, more than can be reasonably cited, have
relied heavily on direct infusion of permethylated glycans.
These experiments, while valuable for in-depth structural
analysis, require the presence of the operator for sample load,
run, and subsequent wash before load of next sample. The
nanoLC-NSI-MSn method we describe here, like other LC-
based methods, is amenable to autosampling, greatly
increasing analytic throughput. Furthermore, data collection is
almost entirely automated compared with more labor-intensive
direct infusion experiments. This marked benefit also highlights
a bottleneck in all glycomic analysis, but especially for LC-
based analysis, namely, facile analysis of large data sets.
Software platforms capable of handling and annotating large
glycan data sets generated by nanoLC-NSI-MSn approaches
are only in their infancy (38). We made use of our in-house
developed GRITS Toolbox to sieve through the data by
providing structural candidates based on MS/MS data (18).
However, neither this platformnor anyother is currently capable
of integrating MSn data for permethylated glycans across an
entire LC run. Furthermore, software packages developed for
LC-based proteomic applications are not ideal for interpreting
LC of permethylated glycans because the underlying as-
sumptions regarding isotopic distributions of amino acids are
not transferable to permethylated monosaccharides.
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Fully automated annotation packages for handling per-
methylated glycan LC-separation data are a significant need for
expanding the adoption of this powerful approach for glyco-
mics. Here, we have provided a useful and robust separation
platform that will facilitate the generation of data essential for
developing and testing such tools. In the meantime, as these
new software tools are developed and implemented, the
expanded ability of our nanoLC-NSI-MSn platform to resolve
and quantify glycan isomers, combined with the capacity for
high-throughput analysis, will provide new opportunities for
investigating the diversity of glycosylation at scales capable of
answering biologically important questions.
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